Kite, a Gilead Company , and its partner Arcellx, today announced new positive data from its pivotal iMMagine-1 Phase 2 study of anitocabtagene autoleucel (anito-cel), an investigational agent, which ...

Safety and efficacy data from a phase 1 multicenter study evaluating rapcabtagene autoleucel, an investigational ...

Patients who receive T-cell redirecting therapies are typically hospitalized for several days after treatment to watch for ...

Newly Appointed Members Include Leaders in Vaccine Immunology, T-Cell Science, and Clinical Research ATLANTA, GA - December ...

NeuMap, the first single‑cell atlas of neutrophils, reveals conserved functional hubs across health, infection, and cancer, reshaping immunity.

The immune system faces a delicate balancing act: it must be aggressive enough to fight infections and cancer, yet restrained enough to avoid attacking the body's own tissues. More than two decades ...

Background Chronic hepatitis B virus (HBV) infection disproportionately affects people living with HIV, who are often excluded from functional cure studies. Objective This study investigates CD8+ T ...

Using a pixel dwell duration of 1.0 ms and an 8 × 8 subpixel scan array, the total dosage per pass was maintained at 18.37 e ...

State officials have asked the justices to allow it to use a newly redrawn map for the 2026 midterms, part of a nationwide redistricting push by President Trump. By Abbie VanSickle Reporting from ...

The Brief keeps Texas voters and political observers up to speed on the most essential coverage of their elected officials, the policies that shape their daily lives and the future of our great state.